RY 172.7 -0.1792% SHOP 152.38 -3.7762% TD 74.49 -0.4144% ENB 58.66 0.2906% BN 80.21 0.2124% TRI 235.76 -0.7034% CNQ 42.27 -1.3305% CP 102.81 -2.4851% CNR 145.02 -0.9426% BMO 139.15 0.5855% BNS 77.045 -0.149% CSU 4497.2998 0.6756% CM 92.23 -0.335% MFC 43.28 0.8858% ATD 79.0 -1.1882% NGT 53.35 -1.8038% TRP 65.26 0.215% SU 49.61 -1.411% WCN 251.65 -0.2181% L 191.14 0.1205%
5N Plus Inc. (TSX: VNP) is a Canada-based company producing specialty chemicals and engineered materials. It provides a range of technologies to manufacture products that its customers use in several advanced electronics, optoelectronics, pharmaceutical, health, renewable energy, and industrial applications.
Key highlights
Source: Company Presentation
Source: Company Presentation
Source: Company Presentation
Source: REFINITIV, Analysis by Kalkine Group
Source: Company Presentation
Risks associated with investment
The company is enclosed with many risk factors such as Interest rates, foreign currency volatility, overseas freight charges, etc. which may limit its ability to execute its strategy to achieve long‐term growth objectives. Furthermore, the company reported a surge in the net debt to USD 80.0 million V/s USD 10.1 million, which exposes it to the rising interest rates burden on its books, implying a significant balance sheet risk.
Financial overview of FY 2021 (in thousands of USD)
Source: Company Filing
Top-10 Shareholders
The top 10 shareholders have been highlighted in the table, which forms around 49.76% of the total shareholding. Caisse de Depot et Placement du Quebec and Letko, Brosseau & Associates Inc. hold the company's maximum interests at 17.95% and 11.42%, respectively. The company's institutional ownership stood at 46.34%. Higher institutional holdings transform the confidence in retail investors.
Valuation Methodology (Illustrative): EV to Sales based Valuation Metrics
Stock recommendation
Despite adverse worldwide business conditions, the company generated considerable sales increase in the fourth quarter and for the whole year. Incremental expenditures related to overseas freight and consumables also had an impact on the results. With the completion of its strategic acquisition of AZUR and a thorough due diligence procedure in Q4 of 2021, the firm built a unique specialty semiconductors platform. The acquisition of AZUR improves the company's value chain, competitive capabilities, and future commercial potential, which is a key positive
Furthermore, the company has seen a solid increase in its order book, which underscores the group's confidence. Moreover, the stock is accessible at a discount on the value front. On a cautionary note, the corporation carries a significant debt burden, implying a significant balance sheet risk. Hence, considering the aforesaid rationales, we recommend a “Speculative Buy” rating in the stock at the closing price of CAD 2.23 on February 22, 2022, with double-digit (percentage term) upside potential.
One-Year Price Chart (as on February 22, 2022). Source: REFINITIV, Analysis by Kalkine Group
Technical Analysis Summary
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.